Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank38
3Y CAGR-18.6%
5Y CAGR-6.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-18.6%/yr
vs +79.7%/yr prior
5Y CAGR
-6.4%/yr
Recent deceleration
Acceleration
-98.3pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $49.98M | -36.6% |
| 2024 | $78.78M | -8.4% |
| 2023 | $86.02M | -7.3% |
| 2022 | $92.83M | -26.8% |
| 2021 | $126.87M | +82.4% |
| 2020 | $69.57M | +137.2% |
| 2019 | $29.33M | +229.4% |
| 2018 | $8.90M | +116.2% |
| 2017 | $4.12M | - |